Drug Development Market Research Reports & Industry Analysis
The drug development industry is dedicated to creating and refining treatments that improve lives and combat diseases. This field is in a state of rapid transformation, driven by advances in technology, regulatory changes, and shifting patient needs. MarketResearch.com provides hundreds of drug development industry reports to allow stakeholders to understand important market trends, challenges, and opportunities with unparalleled clarity.
Drug Development Market Research and Industry Forecasts
- Our wide-ranging reports cover a variety of dynamic markets and provide drug development market size and growth forecasts.
- Additionally, our research includes pipeline assessments of clinical trial products and clinical developments, value chain analysis, price indicators, and more.
- The competitive landscape is also covered in detail, with information on market structure, key players, company overviews, product portfolios, financials, and SWOT analyses.
MarketResearch.com: Your Dedicated Partner
Designed with consultants and busy executives in mind, our reports are powerful tools for enhancing your decision-making process. Our research can help you anticipate market changes and seize emerging opportunities as the drug development industry continues to evolve. Browse our full list of drug development market research reports to get started.
Drug Development Industry Research & Market Reports
-
Live Cell Encapsulation Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... accrediting to the growth of the live-cell encapsulation market is growing public-private investments to fund product development. Furthermore, the increasing research programs to establish the clinical efficacy of the cell encapsulation process is boosting the ... Read More
-
Global Advances in Omics Technologies Enable Future Drug Discovery and Growth Opportunities
... the ability to study omics are transforming drug development. Personalized therapy is on the rise and promises to be more effective and efficient in addressing challenges. With growing interest in personalized and precision medicine, drug ... Read More
-
Drug Discovery Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... USD 53,855 million in 2020, and it is expected to reach 85,785 million by 2026. Amid the COVID-19 pandemic, the health system of countries is rapidly investing in research and development to combat the virus. ... Read More
-
Cancer Therapy Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... of USD 268 billion in 2026, with a CAGR of 9.15% over the forecast period. The COVID-19 pandemic has affected the healthcare systems globally and also has a significant impact on the cancer therapy market. ... Read More
-
2022 Global Forecast for Drug Discovery Informatics (2023-2028 Outlook)-High Tech & Emerging Markets Report
... The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product ... Read More
-
2022 Global Forecast for Drug Discovery Services (2023-2028 Outlook)-High Tech & Emerging Markets Report
... The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product ... Read More
-
Genome Editing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Technology (CRISPR, TALEN, Antisense, and Others), Application (Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery, and Others), and End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations)
... and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations) The genome editing market is projected to reach US$ 16,986.69 million by 2028 from US$ 5,199.40 million in 2021; it is expected to grow ... Read More
-
Peptide Synthesis Market by Reagent (Resins, Amino Acid, Dyes), Equipment (Peptide Synthesizer, Chromatography, Lyophilizer), Technology (Solid-phase, Solution-phase, Hybrid & Recombinant), End User (Pharma, Biotech, CRO) - Global Forecast to 2026
... is projected to reach USD 730 million by 2026 USD 515 million in 2021, at a CAGR of 7.2% during the forecast period. Growth in this market is driven by the increasing use of peptides ... Read More
-
Global Small Molecule API Market 2022-2026
... forecast period. Our report on the small molecule API market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers ... Read More
-
Global Messenger RNA - Epidemiology Forecast - 2032
... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Global Messenger RNA Understanding The ... Read More
-
PD-1 and PD-L1 inhibitors - Pipeline Insight, 2022
... clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global ... Read More
-
Glioblastoma Multiforme (GBM) Treatment Market Share, Size, Trends, Industry Analysis Report, By Treatment (Surgery, Radiation therapy, Chemotherapy, Targeted Therapy, Tumor Treating Field (TTF) Therapy, and Immunotherapy), By Drug Class (Temozolomide, Bevacizumab, Lomustine, Carmustine Wafers, and Others), By End-Use, By Region; Segment Forecast, 2022 - 2030
... Others), By End-Use, By Region; Segment Forecast, 2022 - 2030 The global glioblastoma multiforme (GBM) treatment market size is expected to reach USD 4.82 billion by 2030 according to a new study by Polaris Market ... Read More
-
P38 mitogen-activated protein (MAP) kinase inhibitors - Pipeline Insight, 2022
... pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. ... Read More
-
Hematopoietic progenitor kinase 1 inhibitors - Pipeline Insight, 2022
... profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered ... Read More
-
TrkC receptor antagonists - Pipeline Insight, 2022
... nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage TrkC ... Read More
-
Anaplastic lymphoma kinase inhibitors - Pipeline Insight, 2022
... profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered ... Read More
-
The Global Market for Advanced Fibers 2022-2032
... energy storage and generation (solar cells, lithium batteries, supercapacitor, etc.) biomedical applications (regenerative medicine, drug delivery, tumor therapy, etc) Their use will increase greatly in these and other markets in the next 10-15 years. ... Read More
-
Trk (TrkB) receptor antagonists - Pipeline Insight, 2022
... clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global ... Read More
-
HER2Negative Metastatic Breast Cancer - Epidemiology Forecast to 2032
... EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 HER2Negative Metastatic Breast ... Read More
-
5-HT2A Agonists - Pipeline Insight, 2022
... products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage 5-HT2A Agonists Understanding ... Read More
-
DUX4 protein inhibitors - Pipeline Insight, 2022
... nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage DUX4 ... Read More
-
Anatomic Pathology Market Share, Size, Trends, Industry Analysis Report, By Product; By Application (Disease Diagnosis, Drug Discovery and Development, Others); By End-Use (Hospitals, Research Laboratories, Diagnostic Laboratories, Others), By Region; Segment Forecast, 2022 - 2030
... The global anatomic pathology market size is expected t-reach USD 65.54 billion by 2030, according t-a new study by Polaris Market Research. The report “Anatomic Pathology Market Share, Size, Trends, Industry Analysis Report, By Product; ... Read More
-
Biosimulation Market Share, Size, Trends, Industry Analysis Report, By Product (Software, Services), By Application (Drug Development, Drug Discovery, Others), By End-Use, By Region; Segment Forecast, 2022 - 2030
... to reach USD 8.65 billion by 2030 according to a new study by Polaris Market Research. The report “Biosimulation Market Share, Size, Trends, Industry Analysis Report, By Product (Software, Services), By Application (Drug Development, Drug ... Read More
-
Artificial Intelligence (AI) in Pharmaceutical Market Share, Size, Trends, Industry Analysis Report, By Application (Drug Discovery, Precision Medicine, Medical Imaging & Diagnostics, Research); By Technology; By Offering; By Deployment; By Region; Segment Forecast, 2022 - 2029
... 2029 The global Artificial Intelligence (AI) in pharmaceutical market size is expected to reach USD 7,147.2 million by 2029 according to a new study by Polaris Market Research. The report “Artificial Intelligence (AI) in Pharmaceutical ... Read More
-
WEE1 protein inhibitors - Pipeline Insight, 2022
... nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage WEE1 ... Read More
Research Assistance
